浏览其他金融产品
AbbVie Inc.
ABBV重点摘要
最后更新: 2026-06-22- •艾伯维确认以109亿美元全现金收购Apogee Therapeutics,每股135.11美元,溢价约60%,旨在扩大免疫学管线。
- •ABBV差价合约交易价为216.66美元(-2.10%)——50倍杠杆差价合约在今日215.41-222.32美元的区间内产生约345美元的盈亏波动;杠杆超过100倍的头寸在接近日内低点时面临清算风险。
- •制药同行如强生、默克和百时美施贵宝可能因该交易验证了免疫学资产溢价并预示着进一步的并购意愿而获得同情性重新定价。
- •宏观和跨市场影响微乎其微——这是一项行业特定的知识产权交易,对外汇、大宗商品或广泛指数没有实质性影响。
- •关键关注水平:ABBV支撑位在215.41美元,阻力位在222.32美元;收盘价高于222.32美元将表明市场对交易的战略价值有信心。
价格与市场结构
交易制度状态
最新动态
艾伯维109亿美元收购Apogee:杠杆情景、生物技术重新定价及ABBV差价合约展望
根据PR Newswire的一份新闻稿,艾伯维(NYSE: ABBV)已宣布达成一项最终协议,将以约109亿美元现金收购Apogee Therapeutics(NASDAQ: APGE),收购价为每股135.11美元——这代表着比Apogee先前估值高出约60%的溢价。据Fox Business报道,并经路透社相关消息来源证实,该交易将深化艾伯维的免疫学产品组合,特别是在特应性皮炎及相关炎症性疾病
艾伯维接近以109亿美元全现金收购Apogee Therapeutics — 杠杆情景与生物技术重新定价
根据《金融时报》和彭博社的报道,艾伯维公司(AbbVie Inc.,股票代码:ABBV)正接近以约109亿美元的全现金方式收购Apogee Therapeutics(股票代码:APGE)。该交易尚未得到双方公司的正式宣布,因此是一笔消息来源可靠但未经证实的情况。市场评论认为,公告可能在几天内发布,社交媒体上有人提到APGE“可能在周一以109亿美元的价格被收购”。
Medincell FY26 亏损扩大,受阿布维(AbbVie)试验延迟影响,管线前景蒙阴
Medincell(Euronext Paris: MEDCL)是一家专注于长效注射疗法的商业和临床阶段生物制药授权公司,于 2026 年 6 月 16 日公布了其 2025-26 财年的年度业绩。根据 MarketScreener 的数据,该公司报告的半年度净亏损为 1610 万欧元,高于去年同期的 1460 万欧元亏损,尽管营业亏损小幅改善至 660 万欧元。根据 FirstWord Phar
艾伯维第一季度2025:收入超出预期与调整后的指引提升推动CFD机会 — $197.89的杠杆情景
艾伯维(NYSE: ABBV)于2025年4月25日发布了第一季度业绩,业绩表现混合但偏向于看涨。根据PRNewswire的消息,收入达到$13.343B——同比增长8.4%,大约超出市场预期的$12.93B约5.5亿美元。调整后的每股收益为$2.46,比预估的$2.39高出$0.07。GAAP每股收益为$0.72,因$2.48亿的IPR&D费用(每股影响$0.13)未达预期,详见财报。
Get Started with AbbVie Inc.
Start trading AbbVie Inc. on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade ABBV CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade AbbVie Inc.: Step-by-Step Guide
Learn how to trade AbbVie Inc. (ABBV) on CoinUnited.io with up to 1000x leverage and zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find ABBV in the Stocks Section
Navigate to the stocks market section and search for ABBV. You can trade AbbVie Inc. as a CFD with up to 1000x leverage.
- ✓Search for "ABBV" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade AbbVie Inc..
- ✓Long (buy) if you expect ABBV to rise
- ✓Short (sell) if you expect ABBV to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
标签
免责声明与参考资料
重要风险提示
本平台所提供的所有 AbbVie Inc. 价格预测与分析内容,均仅供参考与教育用途, 不构成任何形式的财务建议、投资推荐或操作指导。
加密货币市场波动剧烈、难以预测,过往表现不代表未来结果。所展示的预测基于数学模型、历史数据分析与多项技术指标,但无法涵盖突发市场事件、监管变化或其他外部因素。
用户在做出任何投资决策前,应自行进行充分研究,并咨询具有专业资质的金融顾问。平台开发方与运营方不对因依赖所提供信息而造成的任何财务损失或其他后果承担责任。
加密资产投资风险极高,可能导致全部本金损失。
方法论概览
我们的 AbbVie Inc. 价格预测采用多因子分析方法,结合以下核心模块:
- 技术分析(移动平均线、振荡指标、图表形态)
- 机器学习模型(LSTM 神经网络、回归模型)
- 链上数据指标(交易量、活跃地址、交易所流量)
- 情绪分析(社交媒体、新闻动态、大众情绪)
- 宏观因素(通胀、利率、与传统市场的相关性)
上次方法论审阅时间:
ABBV
AbbVie Inc.
Live from CoinUnited.io